Skysis Bolsters Avalere’s Market Access Capability in North America

IRA Question of the Week: Which Therapeutic Areas Are Likely to Be Affected by IRA Negotiation?

“Clinical trial participation has not appropriately represented all patient populations.”

reduction to 2024 MA plan payments estimated due to proposed switch of the diagnostic classification used for risk adjustment to ICD-10

“Outcomes-based agreements are increasingly important for CGT market access.”

of people enrolled in the commercial insurance market could be affected by state copay accumulator bans